Learning outcomes
By the end of this lesson you should be able to: define a manic, hypomanic, mixed and depressive episode and apply the duration and severity thresholds that separate them; distinguish bipolar I from bipolar II disorder, cyclothymia and rapid cycling; use the screening questions that identify previously unrecognised bipolarity in a depressed patient; describe the differential including thyroid disease, substance intoxication and stimulant use; and outline the acute and maintenance treatment of mania and bipolar depression, including lithium, valproate, lamotrigine and antipsychotics, and the hazards of prescribing an antidepressant alone.
Prerequisites
Lesson 7 (Schizophrenia spectrum) for psychosis phenomenology, and Lesson 5 for the interview technique that extracts the longitudinal history on which this diagnosis depends.
The big idea
Bipolar disorder is not a mood disorder that happens to be severe; it is a disorder of the regulation of activation with two poles. The manic mood is not happiness in any ordinary sense — patients describe it as pressure, urgency, an inability to be still, irritability and an irritability-driven impatience with others. And the depressive pole, which carries the greater burden of suffering and of suicide, is where the illness does most of its damage. A patient's first presentation is usually depressive, which is precisely why bipolar disorder is missed so often.
The manic syndrome
The diagnosis requires a change from the person's usual state — this is a family member's observation as much as the patient's — and the symptoms cluster around increased energy and reduced sleep.
| Symptom | How it presents | What to ask |
|---|---|---|
| Elevated, expansive or irritable mood | Unusually cheerful, or unreasonably irritable and impatient; a change from previous behaviour | Has anyone said you have been different in the last two weeks? What did they say? |
| Increased activity and energy | More projects, more exercise, more social contact, more spending, more sexual activity | What have you been doing more of than usual? |
| Decreased need for sleep | Waking after two or three hours feeling rested and refreshed, and full of plans from dawn | How many hours did you sleep? Did you wake early and feel fine? |
| Grandiosity | Inflated self-esteem, unrealistic plans, special relationships, special powers or a religious mission | Have you felt you had a special purpose or unusual ability? |
| Pressure of speech | Rapid, loud, difficult to interrupt, often with puns and rhymes | Observe rather than ask: can you get a word in? |
| Flight of ideas or racing thoughts | Thoughts moving so fast that the patient cannot keep up with their own speech | Do your thoughts race so fast you cannot hold on to one? |
| Distractibility | Attention diverted by irrelevant external stimuli | Do you find it hard to finish one thing? |
| Increased goal-directed activity or psychomotor agitation | Work, social, sexual or creative activity; or purposeless movement | What have you started doing? |
| Excessive involvement in pleasurable activities with painful consequences | Spending, sexual indiscretion, reckless driving or investments | Have you done anything you now regret? |
NoteThe severity line is where hypomania ends and mania begins. Mania causes marked impairment or requires admission; hypomania produces an observable change in function without marked impairment and without psychosis. Mood may be elevated or irritable, and increased energy and activity is required in ICD-11 — euphoria alone is not enough.
Mixed features are common and important: during a manic or hypomanic episode, depressive symptoms — low mood, anhedonia, hopelessness, guilt, suicidal ideation — may occur simultaneously. Mixed presentations are diagnostically hazardous, because they resemble agitated depression, and they carry a high suicide risk. Cyclothymia consists of at least two years of persistent instability of mood, with numerous periods of mild hypomanic and depressive symptoms that do not meet full criteria. Rapid cycling, defined as four or more mood episodes in twelve months, is associated with poorer outcome, greater refractoriness, and a poorer response to lithium — and it is frequently iatrogenic through antidepressant use.
Classification and epidemiology
| Disorder | Criteria | Notes |
|---|---|---|
| Bipolar I disorder | At least one manic episode, usually with depressive episodes | Around one percent of the population lifetime; equal sex distribution; mean onset in the early twenties; psychotic features common in mania |
| Bipolar II disorder | At least one hypomanic episode and at least one major depressive episode, and never a manic episode | Probably at least as common as bipolar I; more depressive predominance, more chronicity, more frequent misdiagnosis as unipolar depression |
| Cyclothymic disorder | Two years of fluctuating subsyndromal hypomanic and depressive symptoms without full episodes | A trait-like diathesis to bipolarity; a substantial proportion progress to a full episode |
| Rapid cycling | Four or more mood episodes within twelve months | More common in women; a worse prognosis; avoid antidepressants; often reduced lithium responsiveness |
| Other bipolar and related disorders | Substance- or medication-induced bipolar disorder, and bipolar disorder due to a medical condition | Consider thyroid disease, corticosteroids, stimulants and antidepressants before settling on primary bipolarity |
Watch outThe scenario that hides bipolar disorder is a young adult with several depressive episodes. Two questions change the yield enormously: 'have you ever had a period of days when you felt unusually good, energetic or irritable, when people told you that you seemed different?' and 'have you ever needed much less sleep than usual, without feeling tired the next day?' A positive answer alters the treatment entirely — antidepressants alone risk switching and destabilising the course.
Differential diagnosis
| Condition | Reason it mimics mania | Discriminator |
|---|---|---|
| Unipolar depression with agitation | Restlessness and irritability resemble manic energy | No elevated mood, no decreased need for sleep, and an episodic depressive course; the agitation is in service of anxiety rather than activity |
| Schizoaffective disorder | Psychosis and mood disturbance coexist | Psychosis is present for at least two weeks in the absence of the mood episode in schizoaffective disorder |
| Schizophrenia | Disorganised and agitated behaviour | The disturbance is chronic with no bipolar periodicity; the mood is not elevated |
| Hyperthyroidism | Overactivity, tremor, weight loss, heat intolerance and emotional lability | Goitre, tachycardia, raised T4 and suppressed TSH — always test thyroid function in a first presentation of apparent mania |
| Substance intoxication and withdrawal | Stimulants (amphetamines, cocaine), alcohol intoxication and withdrawal, and phencyclidine produce agitation and grandiosity | Temporal relation to use; resolve after abstinence; always obtain a urine screen and a collateral history |
| Medication-induced mood change | Corticosteroids, antidepressants, L-dopa, dopamine agonists, venlafaxine, interferon alfa | Document recent prescriptions and doses; antidepressant-induced hypomania still counts toward a bipolar diagnosis |
| Personality disorder, particularly borderline | Affective instability and impulsivity | Bipolar episodes are discrete, sustained and separated by euthymia; borderline instability is triggered by interpersonal events and shifts within hours |
| ADHD | Distractibility and overactivity | ADHD is chronic and present from childhood; mania begins later and is episodic; comorbidity is common and hard to disentangle |
Aetiology
Bipolar I is among the most heritable of psychiatric disorders — family, twin and adoption studies give heritability estimates in the region of sixty to eighty-five percent — and the genetic architecture is strongly polygenic with substantial overlap with schizophrenia. Circadian and homeostatic sleep disruption is central: a single night of sleep deprivation can trigger a manic episode in a vulnerable person, and irregular schedules precede relapse; the mechanism involves disturbances of melatonin and cortisol rhythm, and the family of clock genes. Life events are weak precipitants compared with unipolar depression, but childbirth, sleep disruption, interpersonal disruption and medication non-adherence are all potent. Seasonality affects both poles.
Management of mania
The first tasks are safety and setting. The risk profile in a manic episode is driven by impulsivity, spending, sexual indiscretion, driving, exhaustion and loss of insight, and by the risk of dehydration or injury; assess capacity and the need for detention, and ensure that any financial safeguards are considered. Stopping any antidepressant is the first pharmacological act, and in severe or treatment-refractory mania, ECT is highly effective.
| Agent | Role | Practical points |
|---|---|---|
| Second-generation antipsychotics (olanzapine, risperidone, quetiapine, aripiprazole) | First-line for acute mania; sedating agents such as olanzapine and quetiapine help recovery of sleep | Rapid and reliable; monitor metabolic effects and akathisia; long-acting injections where adherence is the issue |
| Valproate | First-line alternative or adjunct, effective in mixed states and rapid cycling | Loading and maintenance dosing; monitor levels and blood count; weight gain and tremor are common |
| Lithium | Effective but slower to act; the gold standard for maintenance and the only mood stabiliser with strong anti-suicidal evidence | Narrow therapeutic index; monitor serum level, renal function, thyroid function and calcium; teratogenic, causing Ebstein anomaly |
| Carbamazepine and oxcarbazepine | Alternatives, particularly if valproate is not tolerated | Enzyme induction with numerous interactions; hyponatraemia; blood dyscrasias and rash |
| Benzodiazepines | Short-term adjunct for agitation and to restore sleep | Lorazepam is usual; for days only, not as maintenance, given dependence and disinhibition |
| ECT | Severe, refractory, or life-threatening mania, and where the patient cannot eat or drink | Most efficacious treatment available in severe mania; consent and capacity are often the obstacles |
Watch outLithium toxicity is a matter of life and death. Above 1.5 mmol/L expect coarse tremor, ataxia, confusion, vomiting and diarrhea; above 2.5 mmol/L, oliguria, seizures, coma and death. Anything that reduces renal clearance precipitates it — dehydration, non-steroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, thiazide diuretics — and pregnant women need careful dose management with a higher loss of clearance after delivery. Patients should be taught to stop lithium and seek help during any illness causing dehydration.
Management of bipolar depression
Depression is the pole that dominates the illness course and the suicide risk, and it is harder to treat. The evidence-based options are quetiapine (which is licensed and effective for bipolar depression), lamotrigine (with slow titration because of the Stevens-Johnson risk), the combination of olanzapine with fluoxetine, and lurasidone where available. Lithium has anti-suicidal and mood-stabilising properties. An antidepressant alone is inappropriate, both because of the switch risk and because there is little evidence of benefit.
Watch outAntidepressant monotherapy in a patient with bipolar disorder is a recognised source of harm. It can precipitate a switch into mania or rapid cycling, destabilise the longitudinal course, and has been associated with worsening outcome. If an antidepressant is ever used, it is only alongside a mood stabiliser or antipsychotic, for a depressive episode, and for the shortest duration compatible with response — with an explicit stop date.
Maintenance and monitoring
| Agent | Place in maintenance | Monitoring required | Principal hazards |
|---|---|---|---|
| Lithium | First-line maintenance, reduces relapse, suicide and mortality | Serum level (aim 0.6-1.0 mmol/L, checked at least annually and after dose changes), creatinine and eGFR, thyroid function, calcium, weight, pregnancy test in women of childbearing potential | Toxicity from any cause of reduced renal clearance; chronic tubulointerstitial nephropathy and nephrogenic diabetes insipidus; hypothyroidism; hyperparathyroidism; teratogenicity |
| Valproate | Alternative, particularly effective for rapid cycling and mixed states | Full blood count, liver function, weight | Highly teratogenic: neural tube defects, neurodevelopmental and autistic-type outcomes. In much of the world, it must not be prescribed to any woman or girl of childbearing potential unless a pregnancy prevention programme is in place and she has been counselled |
| Lamotrigine | Alternative; relatively better for preventing depressive relapse than manic relapse | Dose titration over at least five weeks to reduce rash risk; report any rash immediately | Stevens-Johnson syndrome and toxic epidermal necrolysis; interactions with valproate |
| Second-generation antipsychotics | Maintenance, especially in those responsive in the acute phase | Weight, glucose, lipids, prolactin where symptomatic, and ECG where indicated | Metabolic syndrome, sedation, tardive dyskinesia with long exposure |
Psychosocial treatment is integral rather than adjunctive. Psychoeducation is the single most effective intervention available in reducing relapse, and it addresses adherence, the recognition of prodromes, sleep regularity, the avoidance of antidepressants without supervision, and the repair of the social and occupational wreckage. Interpersonal and social rhythm therapy formalises sleep and routine. Family-focused therapy targets high expressed emotion and criticism. CBT addresses residual depressive symptoms. Employment and social support predict outcome as strongly as any drug.
Common mistakes
Watch outFailing to ask about hypomania in a depressed patient, then prescribing an SSRI. This is the commonest and most consequential error in this lesson. A single question about reduced sleep needs and unusual energy takes twenty seconds and changes the entire treatment plan.
Watch outInterpreting the patient's own account as reliable for a manic episode. Manic patients lack insight into the episode itself and often deny symptoms precisely because of grandiosity. A collateral history from a relative or partner is more valuable than the patient's own account, and the mother's or partner's version is the one to record.
Watch outPrescribing lithium or valproate in a woman of childbearing potential without a pregnancy discussion. Lithium causes Ebstein anomaly and valproate is a potent teratogen; the conversation must include contraception, planning, and the risks of an untreated episode, and it must be documented and repeated, not held once.
Check your understanding
A 24-year-old woman presents with low mood, hopelessness and suicidal ideation. Her partner mentions she has had several episodes this month lasting four or five days in which she talked rapidly, spent heavily and slept only three hours without next-day tiredness. What diagnosis is suggested, and what treatment change does it require?
A patient on lithium for four years develops vomiting, diarrhea and a coarse tremor during an episode of gastroenteritis and presents ataxic and confused. What is happening?
Why is rapid cycling important clinically?
Summary and next
Bipolar disorder is a disorder of activation with two poles. Mania is at least a week of elevated or irritable mood with increased energy and at least three associated symptoms, causing impairment or admission; hypomania is shorter, observable and non-impairing. Bipolar I requires mania, bipolar II requires hypomania plus a major depressive episode, and both require screening for thyroid and substance causes. Lithium, valproate, lamotrigine and second-generation antipsychotics are the mainstays, antidepressant monotherapy is a hazard, and psychoeducation and sleep regularity carry most of the relapse-prevention weight.
Next: depressive disorders. You will see the syndrome that is the commonest reason a patient of any age reaches a doctor, how it is separated from grief and adjustment, and how suicide risk is assessed.
Multiple choice
A patient has had elevated mood with three associated symptoms for at least four days, observed by others, without marked impairment, psychosis or hospitalisation. This is best described as:
Which combination is the most dangerous to prescribe to a patient with bipolar disorder presenting with a depressive episode?
Which monitoring is mandatory in a woman of childbearing potential who is starting valproate for bipolar disorder?
Which finding best distinguishes mania from hyperthyroidism when both produce overactivity and emotional lability?
Which statement about the significance of collateral history in an acute manic episode is correct?